Search 
FAQs & How to use this site
Home | About Us | Contact Us
Policies and Manuals
About SWOG
History SWOG History (5/2014)
 
Manuals
ORP Manual ORP Manual (10/2014)
 
Policies
Policy 01 SWOG Mission Statement (5/2013)
Policy 02 Constitution/ByLaws (09/2016)
Policy 03 Guidelines for Full Group Institutional Members in SWOG (5/2015)
Policy 04 Community Clinical Oncology Program Guidelines (4/2011)
Policy 05 Affiliate Program Membership (4/2012)
Policy 06 Policy Deleted (no download available)
Policy 07 New Investigator Nomination Process (9/2016)
Policy 08 Committee Membership Nominations (5/2013)
Policy 09 Investigator/Clinical Research Associate/Nurse Contribution Sheets (5/2013)
Policy 10 Job Description of Disease and Research Committee Chair (5/2013)
Policy 11 Job Description/Study Coordinator (10/2015)
Policy 12 SWOG Registration and Treatment Policies (5/2015)
Policy 13 Protocol Guidelines (5/2013)
Policy 14 Policy Deleted (no download available) (4/2011)
Policy 15 Applicability of IND Applications and Investigator Brochures/Support From Pharmaceutical Companies (4/2011)
Policy 16 Policy Deleted (no download available)
Policy 17 Cost Containment (5/2013)
Policy 18 Data Evaluation Policy and Procedure (5/2015)
Policy 19 Quality Assurance Program (5/2015)
Policy 20 New Agent Studies and Safety Monitoring (5/2015)
Policy 21 Data and Safety Monitoring (5/2013)
Policy 22 Ethical and Regulatory Considerations (5/2014)
Policy 23 Serious Adverse Events (5/2014)
Policy 24 Procedural Guidelines for All Publication (5/2015)
Policy 25 Drug Ordering (5/2015)
Policy 26 The SWOG Radiation Therapy Quality Assurance Committee (10/2015)
Policy 27 Bone Marrow and Stem Cell Transplantation Guidelines for Institution Approval (5/2014)
Policy 28 Policy Deleted (no download available) (4/2011)
Policy 29 Roster of Investigators Maintenance Policies and Procedures (4/2016)
Policy 30 Responsibility for Patient Follow-Up (5/2015)
Policy 31 HIPAA Privacy Rule Policy (4/2011)
Policy 32 Policy deleted (no download available)
Policy 33 Institutional Performance Review (10/2011)
Policy 34 Industrial Interaction (5/2013)
Policy 35 Financial Conflict of Interest Policy (5/2013)
Policy 36 Affirmation of Integrity (5/2013)
Policy 37 Certification of Education in the Protection of Human Subjects (4/2010)
Policy 38 Dosing Principles for Patients on Clinical Trials (5/2014)
Policy 39 Acquisition, Maintenance and Use in Research of Tissue and Other Biologic Patient Specimens (5/2014)
Policy 40 Membership of Non-United States Institutions (4/2011)
Policy 41 Debarment, Suspension or Other Administrative Actions & Handling of Allegations of Research Misconduct (5/2013)
Policy 42 Policy on Advertising for Subject Recruitment and Trial Promotion (5/2014)
Policy 43 Requests for Patient Data from Investigators and Pharmaceutical Companies (5/2013)
Policy 44 Early Closure of Studies (10/2007)
Policy 45 Press Releases and Media Coverage (10/2009)
Policy 46 Job Description of a Principal Investigator (4/2016)
Policy 47 Intellectual Property Policy (10/2012)
Policy 48 Job Description of Translational Medicine Subcommittee Chair (5/2013)
 
     
SWOG Logo Disclaimer | Copyright ©2000-2017 SWOG. All rights reserved.
Design by nuMedia Group Inc. | Hosting by WorldPost Technologies, Inc.
SWOG is FISMA CertifiedSWOG is FISMA Certified